From Table 1 and Supplementary Table 3, there was no significant association between tumor NACT responses (pathologic and clinical responses) and the patient histological characteristics, including age, family history, menopausal status, maximum tumor diameter, PR status, ER status, HER2 status, Ki-67 status, molecular subtypes, and lymph node status. The gene discussed is ERBB2; the disease is neoplasm.